VOYA Investment Management
RAPP

VOYA Investment Management’s Rapport Therapeutics RAPP Stock Holding History

VOYA Investment Management’s Portfolio RAPP Stock Details RAPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.28M Buy
72,948
+6,799
+10% +$191K ﹤0.01% 1117
2025
Q4 		$2.01M Buy
66,149
+52,808
+396% +$1.46M ﹤0.01% 1214
2025
Q3 		$396K Buy
+13,341
New +$238K ﹤0.01% 1873

Other funds holding RAPP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TGV
TRV GP V Boston, Massachusetts $401M AUM 284.76% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

VOYA Investment Management's RAPP Position: Q1 2026 in Review

VOYA Investment Management increased its Rapport Therapeutics (RAPP) stake by 10% in Q1 2026, buying an estimated $191K and bringing the position to 72,948 shares worth $2.28M. The position accounts for ﹤0.01% of the portfolio, ranked #1117.

VOYA Investment Management first reported a position in RAPP in Q3 2025 and has held it in 3 quarters since. 147 funds tracked by Wall St. Rank hold RAPP as of Q1 2026.

  • VOYA Investment Management held 72,948 shares of Rapport Therapeutics worth $2.28M as of Q1 2026.
  • VOYA Investment Management bought 6,799 Rapport Therapeutics shares in Q1 2026, an estimated $191K.
  • Rapport Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #1117 holding.
  • VOYA Investment Management first reported a position in Rapport Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 147 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.